Hua Ping, Zhao Yuwen, Zeng Qian, Li Lanting, Ren Jingru, Guo Jifeng, Tang Beisha, Liu Weiguo
Department of Neurology, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Front Aging Neurosci. 2022 May 11;14:849462. doi: 10.3389/fnagi.2022.849462. eCollection 2022.
Genetic factors play an important role in the pathogenesis of early-onset Parkinson's disease (EOPD). To date, more than 20 pathogenic genes associated with Parkinson's disease (PD) have been identified. This study aims to explore the mutation spectrum of EOPD and the clinical characteristics of mutation carriers in eastern China.
We recruited 155 unrelated EOPD patients, including 8 familial and 147 sporadic EOPD (age at onset ≤ 50 years). Overall, 24 known PD-associated genes were detected by whole exome sequencing and multiplex ligation-dependent probe amplification (MLPA) from patient samples. The genetic and clinical characteristics of pathogenic/likely pathogenic (P/LP) loci in this cohort were analyzed.
Overall, 14 (9.03%) patients were detected with P/LP variants distributed in seven genes. The most frequent mutation occurred in (7/155, 4.52%), followed by (2/155, 1.29%), , , , and (1/155, 0.64%, respectively). Exon rearrangement mutations accounted for 57.9% (11/19) of all mutations in . Four novel variants were detected: c.14T > C (p.M5T) in , c.297C > A (p.Y99X) in , c.2578C > T (p.R860C) in and c.4C > T (p.Q2X) in . We found the first case of c.6055G > A (p.G2019S) mutation in Chinese population. The median onset age of patients with P/LP mutations in autosomal recessive genes ( and ) was about 18.0 years earlier than patients without mutation. The proportion of patients with mutations were 63.64%, 27.03% and 9.68% when patients were stratified according to the age of onset at ≤ 30, ≤ 40 and ≤ 50 years, respectively.
Early-onset Parkinson's disease patients from eastern China present a regional specific mutation spectrum. Analysis of larger patient cohorts is required to support these findings, and mechanistic studies of the four novel missense/non-sense mutations will clarify their role in the pathogenicity of EOPD.
遗传因素在早发性帕金森病(EOPD)的发病机制中起重要作用。迄今为止,已鉴定出20多种与帕金森病(PD)相关的致病基因。本研究旨在探索中国东部EOPD的突变谱及突变携带者的临床特征。
我们招募了155例无亲缘关系的EOPD患者,包括8例家族性和147例散发性EOPD(发病年龄≤50岁)。总体而言,通过对患者样本进行全外显子组测序和多重连接依赖探针扩增(MLPA)检测了24个已知的PD相关基因。分析了该队列中致病/可能致病(P/LP)位点的遗传和临床特征。
总体而言,14例(9.03%)患者检测到P/LP变异,分布在7个基因中。最常见的突变发生在(7/155,4.52%),其次是(2/155,1.29%)、、、、和(均为1/155,0.64%)。外显子重排突变占所有突变的57.9%(11/19)。检测到4个新变异:中的c.14T>C(p.M5T)、中的c.297C>A(p.Y99X)、中的c.2578C>T(p.R860C)和中的c.4C>T(p.Q2X)。我们在中国人群中发现了首例c.6055G>A(p.G2019S)突变。常染色体隐性基因(和)中携带P/LP突变患者的中位发病年龄比未突变患者早约18.0岁。根据发病年龄≤30、≤40和≤50岁对患者进行分层时,突变患者的比例分别为63.64%、27.03%和9.68%。
中国东部的早发性帕金森病患者呈现出区域特异性的突变谱。需要分析更大的患者队列来支持这些发现,对这4个新的错义/无义突变的机制研究将阐明它们在EOPD发病机制中的作用。